DMARD Tapering Noninferior to Treatment Continuation for RA With Low Disease Activity

TUESDAY, Oct. 13, 2026-- For patients with rheumatoid arthritis (RA) with sustained low disease activity (LDA), structured tapering of biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) is noninferior to treatment...